These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


342 related items for PubMed ID: 17011264

  • 1. The significance of serum hepatocyte growth factor levels in planning follow-up of postoperative jaundice-free patients with biliary atresia.
    Uchida K, Inoue M, Otake K, Yoshiyama S, Toiyama Y, Hiro J, Araki T, Miki C, Kusunoki M.
    J Pediatr Surg; 2006 Oct; 41(10):1657-62. PubMed ID: 17011264
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Elevation of serum galectin-3 and liver stiffness measured by transient elastography in biliary atresia.
    Honsawek S, Chongsrisawat V, Praianantathavorn K, Theamboonlers A, Poovorawan Y.
    Eur J Pediatr Surg; 2011 Aug; 21(4):250-4. PubMed ID: 21487991
    [Abstract] [Full Text] [Related]

  • 4. Serum hepatocyte growth factor and interleukin-6 levels can distinguish patients with primary or metastatic liver tumors from those with benign liver lesions.
    Coskun U, Bukan N, Sancak B, Günel N, Ozenirler S, Unal A, Yucel A.
    Neoplasma; 2004 Aug; 51(3):209-13. PubMed ID: 15254675
    [Abstract] [Full Text] [Related]

  • 5. Kasai portoenterostomy--new insights from hepatic morphology.
    Hussein A, Wyatt J, Guthrie A, Stringer MD.
    J Pediatr Surg; 2005 Feb; 40(2):322-6. PubMed ID: 15750923
    [Abstract] [Full Text] [Related]

  • 6. High levels of serum basic fibroblast growth factor in children with biliary atresia.
    Honsawek S, Chongsrisawat V, Vejchapipat PI, Thawornsuk N, Poovorawan Y.
    Hepatogastroenterology; 2008 Feb; 55(85):1184-8. PubMed ID: 18795654
    [Abstract] [Full Text] [Related]

  • 7. Nephromegaly relates to hepatocyte growth factor dysregulation in biliary atresia.
    Tsau YK, Jou ST, Ni YH.
    Pediatr Nephrol; 2002 Jul; 17(7):554-9. PubMed ID: 12172775
    [Abstract] [Full Text] [Related]

  • 8. Hepatocyte growth factor levels in livers and serum at Kasai-portoenterostomy are not predictive of clinical outcome in infants with biliary atresia.
    Madadi-Sanjani O, Kuebler JF, Dippel S, Gigina A, Falk CS, Vieten G, Petersen C, Klemann C.
    Growth Factors; 2019 Apr; 37(1-2):68-75. PubMed ID: 31185750
    [Abstract] [Full Text] [Related]

  • 9. A high serum interleukin-12p40 level prior to Kasai surgery predict a favourable outcome in children with biliary atresia.
    Wu JF, Kao PC, Chen HL, Lai HS, Hsu HY, Chang MH, Ni YH.
    Liver Int; 2012 Nov; 32(10):1557-63. PubMed ID: 22958268
    [Abstract] [Full Text] [Related]

  • 10. Elevated serum soluble E-selectin is associated with poor outcome and correlated with serum ALT in biliary atresia.
    Vejchapipat P, Sookpotarom P, Theamboonlers A, Chittmittrapap S, Poovorawan Y.
    Eur J Pediatr Surg; 2008 Aug; 18(4):254-7. PubMed ID: 18704886
    [Abstract] [Full Text] [Related]

  • 11. The role of a protease inhibitor against hepatectomy.
    Gotohda N, Iwagaki H, Ozaki M, Konishi M, Nakagohri T, Takahashi S, Yagi T, Kinoshita T, Tanaka N.
    Hepatogastroenterology; 2006 Aug; 53(67):115-9. PubMed ID: 16506388
    [Abstract] [Full Text] [Related]

  • 12. Serum hepatocyte growth factor and clinical outcome in biliary atresia.
    Vejchapipat P, Theamboonlers A, Chaokhonchai R, Chongsrisawat V, Chittmittrapap S, Poovorawan Y.
    J Pediatr Surg; 2004 Jul; 39(7):1045-9. PubMed ID: 15213896
    [Abstract] [Full Text] [Related]

  • 13. Serum hepatocyte growth factor levels in liver diseases: clinical implications.
    Shiota G, Okano J, Kawasaki H, Kawamoto T, Nakamura T.
    Hepatology; 1995 Jan; 21(1):106-12. PubMed ID: 7806142
    [Abstract] [Full Text] [Related]

  • 14. Serum IL-6 and IL-8 in infants with biliary atresia in comparison to intrahepatic cholestasis.
    El-Faramawy AA, El-Shazly LB, Abbass AA, Ismail HA.
    Trop Gastroenterol; 2011 Jan; 32(1):50-5. PubMed ID: 21922857
    [Abstract] [Full Text] [Related]

  • 15. Initial response to portoenterostomy determines long-term outcome in patients with biliary atresia.
    Subramaniam R, Doig CM, Bowen J, Bruce J.
    J Pediatr Surg; 2000 Apr; 35(4):593-7. PubMed ID: 10770389
    [Abstract] [Full Text] [Related]

  • 16. Serum transforming growth factor-beta1 and epidermal growth factor in biliary atresia.
    Vejchapipat P, Theamboonlers A, Poomsawat S, Chittmittrapap S, Poovorawan Y.
    Eur J Pediatr Surg; 2008 Dec; 18(6):415-8. PubMed ID: 19012231
    [Abstract] [Full Text] [Related]

  • 17. Plasma endothelin-1 level as a marker reflecting the severity of portal hypertension in biliary atresia.
    Hasegawa T, Kimura T, Sasaki T, Okada A.
    J Pediatr Surg; 2001 Nov; 36(11):1609-12. PubMed ID: 11685683
    [Abstract] [Full Text] [Related]

  • 18. Elevated serum bone morphogenetic protein 7 levels and clinical outcome in children with biliary atresia.
    Chayanupatkul M, Honsawek S, Vejchapipat P, Chongsrisawat V, Poovorawan Y.
    Eur J Pediatr Surg; 2009 Aug; 19(4):246-50. PubMed ID: 19387926
    [Abstract] [Full Text] [Related]

  • 19. Factors influencing outcome after hepatic portoenterostomy for biliary atresia: a logistic regression analysis.
    Chittmittrapap S, Chandrakamol B, Poovorawan Y, Suwangool P.
    J Med Assoc Thai; 2005 Aug; 88(8):1077-82. PubMed ID: 16404835
    [Abstract] [Full Text] [Related]

  • 20. Hepatic fibrosis scan for liver stiffness score measurement: a useful preendoscopic screening test for the detection of varices in postoperative patients with biliary atresia.
    Chang HK, Park YJ, Koh H, Kim SM, Chung KS, Oh JT, Han SJ.
    J Pediatr Gastroenterol Nutr; 2009 Sep; 49(3):323-8. PubMed ID: 19633573
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.